Online / Physical Event

2nd International Conference on

Cancer Science and Research

Theme: Cancer Research Strengthening to fight against Cancer

Event Date & Time

Event Location

London , UK

Program Abstract Registration Awards

18 years of lifescience communication


Performers / Professionals From Around The Globe

Conference Speaker

Oleg Gerasimenko


Conference Speaker

Julia Gerasimenko


Conference Speaker

Roxana Mirica


Conference Speaker

Dr. Michael Retsky


Conference Speaker

Dr. Donglu Shi


Conference Speaker

Dr. Fabian Schneider


Tracks & Key Topics

Cancer Science 2022


We are glad to announce the 2ndInternational Conference on Cancer Science and Research (Cancer Science 2022) organized in collaboration with generous support and cooperation from enthusiastic academicians and Editorial Board Members scheduled on March 21-22, 2021

Cancer Science 2022 aims at sharing new ideas and technologies amongst the professionals, industrialists and students from research areas of Oncology and Cancer. As the premier event, we have developed a program with your interests in mind. We have not only increased the number of opportunities for you to network with colleagues from across the world but also introduced more focused sessions that will feature cutting-edge presentations, special panel discussions, and livelier interaction with industry leaders and experts.

Cancer Science 2022 invites all the participants from all over the world which includes prompt Keynote talks, Oral talks, Poster presentations, Sponsor Ships and Exhibitions. The aim of this conference is “Cancer Research Strengthening to fight against Cancer”.

Cancer Science Conferences 1000+ CME Global events every year across the globe with support from 1000+ more scientific societies and Publishes 500 Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Who Should Attend??

Cancer Science 2022 conference is a novel discussion to unite overall recognized scholastic Researchers, Public wellbeing experts, Scientists, Doctors, Academic researchers, Industry specialists, Scholars in the field of Oncology, Hematology, Surgery, Nursing, Radiology, Pediatric, Physicians, Advocacy, etc., to exchange about the state of the Research and Development.

Target Audience:

Why Should Attend??

The arranging group assembles eminent speakers covering the most recent advances in the field, fusing differing qualities in each sense. We likewise incorporate talks on most recent methodologies for concentrating these biological inquiries.

Exclusive B2B meetingsInteractive SessionsPanel DiscussionsKeynote SessionsPoster PresentationsOral PresentationsWorkshopsExhibitions etc., are the main highlights of this event.


Scope & Importance:

Cancer Science 2022 and Oncology webinars will seam world-class educators, scientists and Oncologists to converse diverse procedures for Cancer treatmentChemotherapy, and Radiology.

Cancer Science 2022 will be the best platform for all the oncologists, hematologists, research scholars, students who are working in this field to exchange their knowledge related to Oncology Research. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability and quality of life.

Overview of Cancer Science 2022:

The Innovative idea of Cancer has started great much research to be embraced by the labs around the world. With such an extraordinary number of researchers and scientists taking a shot at Caner research, to date, no significant solution for this is recorded. Cancer Science 2022 will manage Cancer Prevention, Diagnosis, and Treatment of illnesses of the Organ-related Cancers and its inventive strategies. Cancer Science 2022 will also supply the two days of discussions on methods and systems identified with administration and satisfactory exchange of Cancer and in addition to check out the new thoughts and ideas on worldwide scale and the themes include Cancer Cell Biology & GeneticsOncologic SubspecialtiesCancer & Stem Cell TherapyCancer MetastasisClinical OncologyCancer Molecular DiagnosticsCancer Immunology and ImmunotherapyNeuro-OncologyGynaec- OncologyHemato- OncologyOncolytic Virus and CancerThe COVID Challenge: OncologyRadiology and Imaging Current TechnologiesSurgical OncologyCancer ChemotherapyPharmaceutical OncologyPediatric OncologyCancer NanotechnologyPathophysiology in CancerCancer NursingCancer: Complementary & Alternative TreatmentsCancer: Life Style Connection, Nutrition & Patient SupportAdvances in Cancer Research And TreatmentClinical Case Reports On Cancer ResearchCurrent Research in Cancer.


Track-1: Cancer Cell Biology & Genetics

Cell division could be a traditional method utilized by the body for growth and repair. Healthy cells stop dividing once there's not a requirement for additional female offspring cells; however cancer cells still turn out copies. Cancer cells square measure cells that divide unrelentingly, forming solid tumors or flooding the blood with abnormal cells. Cancer biology deals with these changes and also the molecular networks that management cell proliferation, differentiation and death. The study of varied styles of cancer is termed as medical specialty.

Track-2: Oncologic Subspecialties

There are several sub-specialties in the field of Oncology. The above mentioned specialties deal with the treatment of cancer through Chemotherapy or Immunotherapy, Biopsies and Radiology respectively.

Track-3: Cancer & Stem Cell Therapy

A stem cell is a cell with the unique ability to develop into specialized cell types in the body. In the future they may be used to replace cells and tissues that have been damaged or lost due to disease.

In stem cell transplants, stem cells replace cells damaged by chemotherapy or disease or serve as a way for the donor's immune system to fight some types of cancer and blood-related diseases, such as leukemia, lymphoma, neuroblastoma and multiple myeloma. These transplants use adult stem cells or umbilical cord blood. Stem cells are not only widely used for regenerative medicine, but are also considered as a useful tool for cancer treatment. For a long time, stem cells have been utilized to renew the immune system for radiation or chemo- therapy treated patients.

Track-4: Cancer Metastasis

The spread of cancer from one part of the body to another part or to lymph nodes, which are not directly connected to each other is called cancer metastasis. Cancer is considered as a deadly disease mainly because of its ability to spread in the body. This metastasis takes place through the blood stream or the lymph system. The most common metastasis parts of the body are the lungs, bones, liver and brain. The metastatic cancer cells does not resemble the feature of the cells where it was found but it resembles the primary cancer cells i.e. it was considered as a next stage of the primary cancer cells. All metastatic cancers are considered as advanced cancers. The cancer survival and treatment is influenced by whether the cancer cells are localized or spreads to other parts. When the cancer starts to spread it is very difficult to control. Even if the treatment is continued, it will be only palliative care. The pain killing will be mostly by Anti-cancer drugs such as chemotherapy. Cancer Management is a multidisciplinary approach that deals with the various type of cancer complications and its preventive measures. Cancer Conferences is an important key for both educational and clinical guidance for managing cancer patients.

Track-5: Clinical Oncology

Clinical oncologists are doctors who treat patients with a balance of radiotherapy and chemotherapy. They are involved in the management of all types of cancer and use a range of other treatments to treat cancers, without using surgery.

They are different than medical oncologists, who use non-radiological treatments for cancer. Clinical oncologists determine which treatment to use by considering a range of factors such as the type of tumor, tumor site, the stage of the disease and the patient’s general health. They assess the relative merits of different treatments before presenting these to the patient.

Track-6: Cancer Molecular Diagnostics

Molecular diagnostics can be used to determine whether a person is at risk for a certain type of cancer. When used this way, the tests may also be referred to as molecular profiling or molecular risk assessment. These tests help a person determine how likely he or she is to develop cancer.

Track-7: Cancer Immunology And Immunotherapy

Cancer immunology is a stream of immunology that studies communications between the immune system and cancer cells (also called tumors or malignancies). It is a field of research that intent to discover cancer immunotherapies to treat and decelerate evolution of the disease. The human immune system mounts natural endogenous response to foreign cells. The gamut of genetics and epigenetics changes occurring in tumors provides diverse set of antigenic repertoire that host’s immune system can exploit to distinguish tumour versus their normal healthy counterparts.

Track-8: Neuro-Oncology

In biology, cell signaling is part of any communication process that governs basic activities of cells and coordinates multiple-cell actions. The ability of cells to perceive and correctly respond to their microenvironment is the basis of development, tissue repair, and immunity, as well as normal tissue homeostasis. Errors in signaling interactions and cellular information processing may cause diseases such as cancer, autoimmunity, and diabetes. By understanding cell signaling, clinicians may treat diseases more effectively and, theoretically, researchers may develop artificial tissues.

All cells receive and respond to signals from their surroundings. This is accomplished by a variety of signal molecules that are secreted or expressed on the surface of one cell and bind to a receptor expressed by the other cells, thereby integrating and coordinating the function of the many individual cells that make up organisms. Each cell is programmed to respond to specific extracellular signal molecules. Extracellular signaling usually entails the following steps:

Track-9: Gynaec- Oncology

Contaminations in the female genitalia and the extra sex organs are regularly known as Gynecologic Infectious Diseases. A portion of the irresistible infections is Vulvovaginitis, Cervicitis, Pelvic Inflammatory Diseases, and Sexually Transmitted Diseases. Gynecologic Oncology is a specific field that arrangements with growths relating to the female genitalia and conceptive framework.

Track-10: Hemato- Oncology

A hematologist-oncologist is a physician, specializes in diagnosing, treatment and prevention of blood diseases and cancers such as iron-deficiency anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. This physician is trained in hematology — the study of blood — and oncology — the study of cancer.

Track-11: Oncolytic Virus And Cancer

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic viruses are thought not only to cause direct destruction of the tumor cells, but also to stimulate host anti-tumor immune system responses. The potential of viruses as anti-cancer agents was first realized in the early twentieth century, although coordinated research efforts did not begin until the 1960s. A number of viruses including adenovirus, reovirus, measles, herpes simplex, Newcastle disease virus, and vaccine have been clinically tested as oncolytic agents. Most current oncolytic viruses are engineered for tumor selectivity, although there are naturally occurring examples such as reovirus and the Seneca virus, resulting in clinical trials.

Track-12: The COVID Challenge: Oncology

The recent Chinese experience suggests that cancer patients are at higher risk of infection to SARS-CoV-2 compared to the general population, which could be related to the closer medical follow-up organized in such fragile patients. More concerning, the risk of severe respiratory complications requiring intensive care unit was much higher in cancer patients compared to non-cancer patients. A covariate significantly associated with this risk was a history of chemotherapy or surgery in the previous months, a feature that involves the highest number of cancer patients. Finally, the cancer patients deteriorated more rapidly than those without cancer.

Track-13: Radiology And Imaging Current Technologies

Radiology is the medical discipline that uses medical imaging to diagnose and treat diseases within the bodies of both humans and animals. A variety of imaging techniques such as X-ray radiography, ultrasound, computed tomography (CT), nuclear medicine including positron emission tomography (PET), and magnetic resonance imaging (MRI) are used to diagnose or treat diseases. Interventional radiology is the performance of usually minimally invasive medical procedures with the guidance of imaging technologies such as those mentioned above.

Track-14: Surgical Oncology

Surgical oncology is the branch of surgery applied to oncology; it focuses on the surgical management of tumors, especially cancerous tumors.

As one of several modalities in the management of cancer, the specialty of surgical oncology, before modern medicine the only cancer treatment with a chance of success, has evolved in steps similar to medical oncology (pharmacotherapy for cancer), which grew out of hematology, and radiation oncology, which grew out of radiology.

Track-15: Cancer Chemotherapy

Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects. Cancer can be treated by surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy and synthetic lethality.

Track-16: Pharmaceutical Oncology

A multidisciplinary way to deal with redesign has been connected in a variety of settings in clinical oncology, especially among patients with stomach and colorectal malignancy. Cancer has one of the highest mortality rates of all diseases worldwide. As a pre-treatment prior to hematopoietic progenitor cell transplantation carried out as a part of treatment for all forms of blood cancer, this drug is contributing to patients as a necessary drug that ranks alongside radiation therapy. Hepatitis B antibody was disease counteractive action antibodies upheld Drug Administration (FDA). Disease treatment immunizations were likewise considered restorative antibodies.

Track-17: Paediatric Oncology

Pediatric Oncology is the term used to comprise all malignant conditions among neonates & children with cancer. The most common childhood cancers are, Neuroblastoma, Retinoblastoma, Wilms tumor and brain tumors, such as gliomas. Childhood cancers are very rare and may differ from adult cancers in the way they grow, spread, treated, and respond to treatment.

Track-18: Cancer Nanotechnology

Cancer nanotechnology is a branch of nanotechnology concerned with the application of both nanomaterial (such as nanoparticles for tumor imaging or drug delivery) and nanotechnology approaches (such as nanoparticle-based theranostics) to the diagnosis and treatment of cancer.

Track-19: Pathophysiology In Cancer

Pathologists are among the most important members of a patient’s cancer care team. They work to diagnose and determine the stage of cancer, setting the course for what comes next in the treatment journey. Pathology is the service that handles the blood samples and the cells and tissues removed from suspicious ‘lumps and bumps’. Cancer pathology’s key role in diagnosing and treating a complex disease, it’s important to stay up to date on new technologies and breakthroughs that continue to shape the ever-evolving landscape of cancer care.

Track-20: Cancer Nursing

Oncology Nursing is a field including practice incorporates the jobs of direct guardian, instructor, specialist, head, and scientist. Oncology nursing care can defined as meeting the various needs of oncology patients during the time of their disease including appropriate screenings and other preventative practices, symptom management, care to retain as much normal functioning as possible, and supportive measures upon end of life. Cancer Summit 2019 will make another transformation in malignancy science and disease nursing field.

Track-21: Cancer: Complementary & Alternative Treatments

Complementary and alternative are terms used to describe many kinds of products, practices, and systems that are not part of mainstream medicine. You may hear them used to refer to methods to help relieve symptoms and improve quality of life during cancer treatment. We call these “complementary” because they are used along with your medical treatment.

Track-22: Cancer: Life Style Connection, Nutrition & Patient Support

Many factors impact the development of cancer. Over the last 25 years, science has displayed that diet,body weight and physical activity —especially being overweight or obese—are leading risk factors for obtaining certain types of cancer. The main behavioral and environmental risk factors for cancer death in the world are related to diet and physical inactivity, use of addictive substances, sexual and reproductive health and exposure to air pollution and use of contaminated needles.

Track-23: Advances In Cancer Research And Treatment

Instruments are designed to aid in the diagnosis, monitoring or treatment of medical conditions. Several new types of equipment are used in the treatment of cancer such as:

Linear Accelerator (LINAC) – It emits radiation of highly localised (X-rays) and it is useful in the treatment of cancer. The 6 MeV linear accelerator having the capability of surface electron allows treating cancer cells even under the subcutis layer overlying the cranium. The patient can also see his activity through the connected display unit.

Gamma Camera – It is used in the detection of cancer via gamma rays. Here tracers used are introduced into the patient’s body intravenously, thus getting the image on the gamma camera as the tracer emits gamma rays which are detected by the gamma camera.

Radiography and Ultrasound – It is a non-invasive way of getting the image of the internal organs by ultrasound. It is a useful method for cancer patients for examining the abdomen for any enlargement of the lymph or masses.

Track-24: Clinical Case Reports On Cancer Research

A case study is a research method involving an up-close, in-depth, and detailed examination of a concerned case (subject/topic), as well as its related contextual conditions. Case studies can be produced by a formal research method followed by an individual, organization, event, or action, existing in a specific time and place. Here we are inviting case studies based on any types of cancer or related incidents or events with facts and figures. Presenting your studies on any other type of cancer in this category will privilege you with a 30% discount on registration.

Track-25: Current Research In Cancer

Leukemia, Lymphoma, Germ cell tumors and early stage solid tumors which were once incurable have become curable malignancies now. Immunotherapies have already proven efficient in leukemia, bladder cancer and various skin cancers. For the future, research is promising in the field of physical oncology. Survival of cancer has significantly improved over the past years due to improved screening, diagnostic methods and treatment options with targeted therapy. Large multi-centric Phase III randomized controlled clinical trials by the National Surgical Adjuvant Breast & Bowel Project (NSABP), Medical Research Council (MRC), and the European Organization for Research and Treatment of Cancer (EORTC) and National Cancer Institute (NCI) have contributed significantly to the improvement in survival.


As per Centers for Disease Control and Prevention (CDC), chronic HBV affected almost 1.4 million of the US population in 2011 and acting as major public health challenge. In past couple of years outbreaks for different infections have deteriorated the situation. All these reports direct towards the increasing need for immunological diagnosis and treatment for infections across the world. Therefore the market for this infection oncology may grow with significant rate in near future. On the other hand high cost involved and limited reach of this technology may hinder the growth of the market

However the growth of the market may be significant in emerging economies in Asia and Africa considering high incidence and prevalence rate for infections. This market can also be segmented according various categories of infections such as hepatitis viruses, retroviruses and other infections. The market has different classes of products used such as reagentsdiagnostic kits, instruments and others. 

Precision Medicine Market size was over USD 39 billion in 2015, and is anticipated to grow at 10.5% CAGR from 2016 to 2023.

Statistics of Physicians, Researchers and Academicians working on Molecular Medicine and Oncology section.

Academia       35%

Researchers    35%

Physicians      25%

Others             5% 

Cancer Drug Market: Overview

Development of some new drugs with success rate is expected to offer the good opportunity for oncology drug market. Wide-ranging scope of cancer immunotherapy agents in different cancer treatments would provide the maximum share to oncology drug market in the forecast period. Pharmaceutical companies and R&D are showing increased interest in this field and is expected to offer better potential for oncology drug market. Companies involved in partnership and R&D for efficient technologies is some of the latest trends that have been observed in oncology drug market. Currently, most of the cancer drugs are in clinical trial and are expected to rise the oncology market after clearance or success of these products from clinical trials.

Growth rate of Cancer Science and research:

A new report from business intelligence provider GBI Research - Global Oncology Market to 2022 - states that the global oncology treatment market is set to expand from the $61.5 billion in 2015 to an estimated $74.2 billion in 2022, despite the imminent expiry of a host of cancer treatments.

Cancer Drug Market: Key Market Participants

Currently various established companies in diagnostic and healthcare segment catering varied range of products such as reagents, test kits and instruments in this market out of which companies such as F. Hoffmann-La Roche Ltd., Abbott LaboratoriesShanghai Kehua Bio-engineering Co., Ltd, Trans Asia Bio-Medicals LtdSpan Diagnostics LtdThermo Fisher Scientific Inc.Bio-Rad Laboratories, Inc. are leading contributors in reagents and test kits, on the other hand Siemens Healthcare and PerkinElmer, Inc. are major companies in Instruments segment.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends.


The age-standardized rate for all cancers (including non-melanoma skin cancer) for men and women combined was 197.9 per 100,000 in 2018. The rate was higher for men (218.6 per 100,000) than women (182.6 per 100,000).

With the burden growing in almost every country, prevention of cancer is one of the most significant public health challenges of the 21st century. Around 40% of cancer cases could be prevented by reducing exposure to cancer risk factors including diet, nutrition and physical activity – for more information see our Cancer Prevention Recommendations or read our blog.

Reducing the cancer burden requires concerted and integrated action from all sectors of society, including civil society, private sector, and health and other professions. You can read what policy actions different countries are taking to promote healthier diets in our NOURISHING framework and accompanying database.

Age-standardized rates are used in the tables. This is a summary measure of the rate of disease that a population would have if it had a standard age structure. Standardization is necessary when comparing populations that differ with respect to age because age has a powerful influence on the risk of dying from cancer.

Cancer associations all over the world:

List of Cancer Hospitals all over the world:

No. of deaths caused by cancer, World 2019 statistics:

Cancer is a generic term for a large group of diseases that can affect any part of the body. Other terms used are malignant tumors and neoplasms. One defining feature of cancer is the rapid creation of abnormal cells that grow beyond their usual boundaries, and which can then invade adjoining parts of the body and spread to other organs, the latter process is referred to as metastasizing. Metastases are a major cause of death from cancer.

Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer.

Approximately 70% of deaths from cancer occur in low- and middle-income countries.

Around one third of deaths from cancer are due to the 5 leading behavioral and dietary risks: high body mass index, low fruit and vegetable intake, lack of physical activity, tobacco use, and alcohol use.

Tobacco use is the most important risk factor for cancer and is responsible for approximately 22% of cancer deaths.

Cancer causing infections, such as hepatitis and human papilloma virus (HPV), are responsible for up to 25% of cancer cases in low- and middle-income countries.

Late-stage presentation and inaccessible diagnosis and treatment are common. In 2017, only 26% of low-income countries reported having pathology services generally available in the public sector. More than 90% of high-income countries reported treatment services are available compared to less than 30% of low-income countries.

The economic impact of cancer is significant and is increasing. The total annual economic cost of cancer in 2010 was estimated at approximately US$ 1.16 trillion.

Only 1 in 5 low- and middle-income countries have the necessary data to drive cancer policy.

Cancer is a leading cause of death worldwide, accounting for an estimated 9.6 million deaths in 2019. The most common cancers are:

World Wide Cancer Universities:

List of Cancer University in USA:

List of Cancer University in Europe:

List of Cancer University in Asia:

List of Cancer University in Africa:

World Wide Oncology and Cancer Based Companies

List of Oncology and Cancer based Companies in the USA:

List of Oncology and Cancer Based Companies in Europe:

List of Oncology and Cancer Based Companies in Asia:

List of Oncology and Cancer Based Companies in Africa:

World Wide Cancer Journals

List of Cancer Journals in USA:

List of Cancer Journals in in Europe:

List of Cancer Journals in Asia:

List of Cancer Journals in Africa:


Cancer Science 2021 Report

The International Webinar on Cancer Science and Research was held on during July 12-13, 2021 with the presence of professional researchers, scientists involved in the development of high-quality education & research in all aspects.

Cancer Science 2021 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various topics related to the field of Cancer Science and Research. The highly exalted conference hosted by Euroscicon was marked with the attendance of renowned and brilliant researchers, business delegates and talented student communities representing more than 20 countries around the world. The conference has tried grounding every aspect related to Cancer Science and Oncology, covering all the possible research areas.

The conference aimed a parallel rail with theme “Cancer Research Strengthening to fight against Cancer”. The meeting engrossed a vicinity of cognizant discussions on Cancer Science and Research, Oncologic Subspecialties, Cancer Cell Biology & Genetics, Tumor Biology, Cancer Metastasis, Stem Cell Therapy in Oncology, Cancer Molecular Diagnostics, The COVID-19 Challenge: Oncology, Medical Oncology, Neuro-Oncology, Neonatal & Pediatric Oncology, Oncolytic Virus, Oncogenomics, Oncology Nursing & Care, Cancer Chemotherapy, Nanotechnology In Oncology Treatment, Cancer Awareness, Life-Style & Nutrition, Cancer: Complementary & Alternative Treatments, Advances in Cancer Research And Treatment, Current Research in Cancer.. The Webinar implanted a firm relation of upcoming strategies in the field of Cancer Science with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

We are thankful to all our speakers for encouraging and supporting us to conduct the conference and catapulting the same to pinnacle of success.

The Organizing Committee would like to thank the moderator for his valuable contribution which resulted in smooth functioning of the conference.

The meeting was embarked with an opening ceremony followed by Keynote Sessions and followed by series of lectures delivered by Honorable Guests and members of the Keynote forum. The highlights of the meeting were the eponymous lectures, delivered by:

Oleg Gerasimenko, Cardiff University, United Kingdom
Julia Gerasimenko, Cardiff University, United Kingdom
Roxana Mirica, Carol Davila University of Medicine and Pharmacy, Romania

All of them provided their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

EuroSciCon is prerogative to thank the Organizing Committee Members, Keynote speakers and Chairs on transcribing the plenary sessions in a diversified and variegate manner to make this Webinar an enviable artefact.

We also express our sincere thanks to all the media partners for the promotion of our event to glory.

Cancer Science 2021 would not have reached the pinnacle if not with the support of International, multi-professional steering committee and coordination of the Research Journal of Oncology, Cancer Biology and Therapeutic Oncology.

With the grand success of Cancer Science 2021, we are glad to announce our next upcoming conference “2nd International Conference on Cancer Science and Research” which is going to be held in London, UK during March 21-22, 2022.

Bookmark your dates…

Hoping to meet you again coming year at London!!!

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!


A huge thanks to all our amazing partners. We couldn’t have a conference without you!